James Howard-Tripp

James Howard-Tripp is a declared insider of GeneNews Limited, with filings sourced from SEDI. Over a trading history stretching from 1 September 2016 to 14 July 2017, the count stands at 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 14 July 2017: an option exercise of €25k, in GeneNews Limited. Half of the filings or more reach the SEDI feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.